Korean J Pediatr Infect Dis.  2008 Dec;15(2):115-120. 10.14776/kjpid.2008.15.2.115.

Post-Marketing Surveillance Study of Hepatitis A Vaccine in Korean Population

Affiliations
  • 1Department of Pediatrics, Fatima Hospital, Changwon, Korea. msh6517@hanmail.net
  • 2Department of Pediatrics, Our Lady of Mercy Hospital, College of Medicine The Catholic University, Incheon, Korea.
  • 3GlaxoSmithKline Biologicals, Rixensart, Belgium.

Abstract

PURPOSE
This post-marketing surveillance (PMS) study was conducted in Korea to assess the safety and reactogenicity of hepatitis A vaccine (GlaxoSmithKlineBiologicals'Havrixâ„¢) administered to the Korean population.
METHODS
A total of 1,188 healthy subjects with 1,122 subjects < 6 years of age were enrolled to receive one dose of the hepatitis A vaccine from April 2005 to January 2006. Diary cards were provided to the subjects or subjects' parents for reporting solicited and unsolicited symptoms during the 4-day and 31-day post-vaccination follow-up period.
RESULTS
The number of subjects who returned diary cards was 568, whereas, 620 subjects did not return diary cards. Among the subjects who returned diary cards, 9.9% and 14.3% reported local and general solicited/unsolicited symptoms. Among the subjects who did not return diary cards, 1.6% and 8.4% reported local and general solicited/unsolicited symptoms. At least one unsolicited symptom was reported by 13.2% of the subjects.
CONCLUSION
Results indicate that the vaccine was well-tolerated and had an acceptable safety profile. The use of diary cards in such a survey provided a prompt and reliable option for recording symptoms.

Keyword

Hepatitis A vaccine; Diary cards; Post-marketing surveillance

MeSH Terms

Follow-Up Studies
Healthy Volunteers
Hepatitis A Vaccines*
Hepatitis A*
Hepatitis*
Humans
Korea
Parents
Hepatitis A Vaccines

Cited by  1 articles

Problems within the post-marketing surveillance system in Korea: Time for a change
Hyoyoung Song, Dong-Seok Yim
Transl Clin Pharmacol. 2016;24(2):63-65.    doi: 10.12793/tcp.2016.24.2.63.

Full Text Links
  • KJPID
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr